Immunosuppression, IBD, and risk of lymphoma

Immunosuppressive therapy is well recognised as increasing the risk of developing non-Hodgkin's lymphoma (NHL) in organ transplant patients. 1 The risk of NHL is increased in other inflammatory conditions, such as rheumatoid arthritis 2 and psoriasis, although how much is attributable to the un...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2002-08, Vol.51 (2), p.296-296
Hauptverfasser:	Bebb, J R, Aithal, G P, Logan, R P H
Format:	Artikel
Sprache:	eng
Schlagworte:	Confidence intervals Humans immunosuppression Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Inflammatory bowel disease Inflammatory Bowel Diseases - complications Inflammatory Bowel Diseases - drug therapy Letter Lymphoma Lymphoma - chemically induced Lymphoma - complications Risk Statistics as Topic Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Immunosuppressive therapy is well recognised as increasing the risk of developing non-Hodgkin's lymphoma (NHL) in organ transplant patients. 1 The risk of NHL is increased in other inflammatory conditions, such as rheumatoid arthritis 2 and psoriasis, although how much is attributable to the underlying disease and how much is due to the drug is unclear.
ISSN:	0017-5749 1468-3288 1458-3288
DOI:	10.1136/gut.51.2.296